Juva Life
Vertically integrated cannabis life sciences and research company.
| Date | Investors | Amount | Round |
|---|---|---|---|
| N/A | €0.0 | round | |
* | $11.8m | Post IPO Debt | |
| Total Funding | 000k | ||
| USD | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|
| Revenues | 0000 | 0000 | 0000 | 0000 |
| % growth | - | - | 300 % | 49 % |
| EBITDA | 0000 | 0000 | 0000 | 0000 |
| % EBITDA margin | - | (1085 %) | (257 %) | (138 %) |
| Profit | 0000 | 0000 | 0000 | 0000 |
| % profit margin | - | (1679 %) | (294 %) | (182 %) |
| EV | 0000 | 0000 | 0000 | 0000 |
| EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x |
| EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x |
| R&D budget | 0000 | 0000 | 0000 | 0000 |
Source: Company filings or news article
Related Content
Juva Life, Inc. is a life sciences company focused on the cannabis sector, operating a vertically integrated business model that encompasses cultivation, manufacturing, research and development, distribution, and retail. Founded in 2018 by Doug Chloupek, the company is headquartered in Vancouver, Canada, with its core operations centered in California. Juva Life aims to develop evidence-based therapeutic and wellness products derived from cannabis, combining its commercial operations with a pharmaceutical-grade research division.
The company's founder and CEO, Doug Chloupek, has extensive experience in the California cannabis market, having established multiple successful cannabis businesses since 2009, including cultivation, manufacturing, and retail operations. His journey began with the MedMar Healing Center dispensary and later co-founding BAS Research, which obtained the first license for cannabis manufacturing and research in Berkeley, California, in 2016. This background informed the creation of Juva Life, which was established to merge commercial cannabis operations with rigorous scientific research to validate the medicinal efficacy of cannabis products.
Juva Life's business is structured into two main arms: a cannabis operations segment and a life science research segment. The cannabis arm generates revenue through the cultivation, production, and sale of medical and recreational cannabis products, including branded and white-label goods. This includes a network of retail and delivery services in California, with locations in Redwood City, Stockton, and Hayward. The revenue from these commercial activities is intended to support the company's research division. The research division is focused on identifying and developing novel cannabis-based compounds for therapeutic applications, such as its Juva-019 and Juva-041 candidates targeting inflammation. By managing the entire lifecycle from cultivation to consumer, Juva Life seeks to ensure product consistency and gather legitimate data for its research endeavors.
Keywords: cannabis life sciences, medical cannabis, cannabis research, vertically integrated cannabis, cannabinoid therapeutics, cannabis cultivation, pharmaceutical development, cannabis retail, cannabis delivery, Doug Chloupek, Juva-019, Juva-041, inflammation treatment, California cannabis, cannabis manufacturing, cannabis distribution, therapeutic cannabis, wellness products, evidence-based cannabis